Annual long term liabilities:
$252.23M+$18.04M(+7.70%)Summary
- As of today (September 16, 2025), XERS annual total long term liabilities is $252.23 million, with the most recent change of +$18.04 million (+7.70%) on December 31, 2024.
- During the last 3 years, XERS annual long term liabilities has risen by +$122.14 million (+93.89%).
- XERS annual long term liabilities is now at all-time high.
Performance
XERS Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$258.82M+$3.31M(+1.30%)Summary
- As of today (September 16, 2025), XERS quarterly total long term liabilities is $258.82 million, with the most recent change of +$3.31 million (+1.30%) on June 30, 2025.
- Over the past year, XERS quarterly long term liabilities has increased by +$247.78 million (+2245.65%).
- XERS quarterly long term liabilities is now at all-time high.
Performance
XERS quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
XERS Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.7% | +2245.7% |
| 3 y3 years | +93.9% | +515.4% |
| 5 y5 years | +275.3% | +118.2% |
XERS Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.9% | at high | +3111.6% |
| 5 y | 5-year | at high | +275.3% | at high | +3111.6% |
| alltime | all time | at high | +632.2% | at high | +3111.6% |
XERS Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $258.82M(+1.3%) |
| Mar 2025 | - | $255.51M(+3070.5%) |
| Dec 2024 | $252.23M(+7.7%) | $8.06M(-96.9%) |
| Sep 2024 | - | $258.41M(+2242.0%) |
| Jun 2024 | - | $11.03M(+27.7%) |
| Mar 2024 | - | $8.64M(-67.6%) |
| Dec 2023 | $234.19M(+3.8%) | $26.69M(+136.1%) |
| Sep 2023 | - | $11.30M(-8.9%) |
| Jun 2023 | - | $12.41M(-4.0%) |
| Mar 2023 | - | $12.92M(-56.0%) |
| Dec 2022 | $225.71M(+73.5%) | $29.35M(-28.3%) |
| Sep 2022 | - | $40.91M(-2.7%) |
| Jun 2022 | - | $42.06M(+13.6%) |
| Mar 2022 | - | $37.04M(-12.6%) |
| Dec 2021 | $130.09M | $42.39M(-56.0%) |
| Sep 2021 | - | $96.44M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $96.14M(+0.3%) |
| Mar 2021 | - | $95.83M(-1.4%) |
| Dec 2020 | $97.18M(+44.6%) | $97.18M(-24.7%) |
| Sep 2020 | - | $129.02M(+8.7%) |
| Jun 2020 | - | $118.64M(+75.7%) |
| Mar 2020 | - | $67.51M(+0.4%) |
| Dec 2019 | $67.21M(+95.1%) | $67.21M(+0.8%) |
| Sep 2019 | - | $66.65M(+75.0%) |
| Jun 2019 | - | $38.09M(-5.9%) |
| Mar 2019 | - | $40.46M(+17.5%) |
| Dec 2018 | $34.45M(-64.8%) | $34.45M(+0.5%) |
| Sep 2018 | - | $34.26M(+73.7%) |
| Jun 2018 | - | $19.73M(+1.1%) |
| Mar 2018 | - | $19.52M(-80.1%) |
| Dec 2017 | $97.97M(+55.7%) | $97.97M |
| Dec 2016 | $62.94M | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual long term liabilities year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly long term liabilities year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual total long term liabilities?
The current annual long term liabilities of XERS is $252.23M
What is the all time high annual long term liabilities for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual total long term liabilities is $252.23M
What is Xeris Biopharma Holdings, Inc. annual long term liabilities year-on-year change?
Over the past year, XERS annual total long term liabilities has changed by +$18.04M (+7.70%)
What is Xeris Biopharma Holdings, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of XERS is $258.82M
What is the all time high quarterly long term liabilities for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly total long term liabilities is $258.82M
What is Xeris Biopharma Holdings, Inc. quarterly long term liabilities year-on-year change?
Over the past year, XERS quarterly total long term liabilities has changed by +$247.78M (+2245.65%)